Cargando…
Therapeutic angiogenesis in cardiovascular disease
Atherosclerotic disease of the arteries is a major cause of coronary artery disease, peripheral vascular disease and stroke. Some patients are however not candidate for the standard treatment of angioplasty or bypass surgery. Hence there is tremendous enthusiasm for the utilization of angiogenesis a...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169246/ https://www.ncbi.nlm.nih.gov/pubmed/18021404 http://dx.doi.org/10.1186/1749-8090-2-49 |
_version_ | 1782144856851742720 |
---|---|
author | Al Sabti, Hilal |
author_facet | Al Sabti, Hilal |
author_sort | Al Sabti, Hilal |
collection | PubMed |
description | Atherosclerotic disease of the arteries is a major cause of coronary artery disease, peripheral vascular disease and stroke. Some patients are however not candidate for the standard treatment of angioplasty or bypass surgery. Hence there is tremendous enthusiasm for the utilization of angiogenesis as a therapeutic modality for atherosclerotic arterial disease. This augmentation of physiological neo-vascularization in cardiovascular disease can be achieved through different pathways. In this article we are reviewing the Use of Gene therapy, Protein therapy and cellular therapy. |
format | Text |
id | pubmed-2169246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-21692462007-12-29 Therapeutic angiogenesis in cardiovascular disease Al Sabti, Hilal J Cardiothorac Surg Review Atherosclerotic disease of the arteries is a major cause of coronary artery disease, peripheral vascular disease and stroke. Some patients are however not candidate for the standard treatment of angioplasty or bypass surgery. Hence there is tremendous enthusiasm for the utilization of angiogenesis as a therapeutic modality for atherosclerotic arterial disease. This augmentation of physiological neo-vascularization in cardiovascular disease can be achieved through different pathways. In this article we are reviewing the Use of Gene therapy, Protein therapy and cellular therapy. BioMed Central 2007-11-16 /pmc/articles/PMC2169246/ /pubmed/18021404 http://dx.doi.org/10.1186/1749-8090-2-49 Text en Copyright © 2007 Al Sabti; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Al Sabti, Hilal Therapeutic angiogenesis in cardiovascular disease |
title | Therapeutic angiogenesis in cardiovascular disease |
title_full | Therapeutic angiogenesis in cardiovascular disease |
title_fullStr | Therapeutic angiogenesis in cardiovascular disease |
title_full_unstemmed | Therapeutic angiogenesis in cardiovascular disease |
title_short | Therapeutic angiogenesis in cardiovascular disease |
title_sort | therapeutic angiogenesis in cardiovascular disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169246/ https://www.ncbi.nlm.nih.gov/pubmed/18021404 http://dx.doi.org/10.1186/1749-8090-2-49 |
work_keys_str_mv | AT alsabtihilal therapeuticangiogenesisincardiovasculardisease |